TGFB1 and urinary bladder carcinoma: To assess the CAPE treatments involved in Smad pathways in bladder carcinoma cells, we determined whether CAPE treatment attenuated the TGFβ-induced phosphorylation of Smad 2/3 and Smad 1/5.